Texas 2017 - 85th Regular

Texas House Bill HB2791

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the state plan for hepatitis C prevention, testing, and treatment.

Impact

The proposed legislation emphasizes increasing accessibility to hepatitis C testing and treatment, particularly for uninsured or underinsured patients. It encourages healthcare providers to implement these interventions, specifically in rural and medically underserved areas. By considering the application of telemedicine, the bill aims to broaden the reach of healthcare services, thereby improving patient outcomes across Texas. This approach reflects a significant shift in public health policy, aligning with contemporary health practices focused on accessibility and preventative care.

Summary

House Bill 2791 focuses on enhancing the state's strategic framework to address the prevention, testing, and treatment of hepatitis C. The bill mandates the Department of Health to develop a comprehensive state plan targeting specific demographics that are disproportionately affected by the disease. This includes individuals infected with HIV, veterans, racial or ethnic minorities, people engaging in high-risk behaviors such as intravenous drug use, and those born between 1945 and 1965. The aim is to tailor interventions to meet the unique needs of these populations.

Contention

Despite its benefits, there may be discussions around funding and resource allocation for implementing this ambitious plan. Supporters argue that ensuring equitable access to health services is crucial for managing chronic diseases like hepatitis C, while some stakeholders may question the practicality of the proposed measures in regions with limited healthcare infrastructures. Moreover, the effectiveness of relying on telehealth services might be debated, especially in acknowledging the barriers many patients face in accessing these technologies.

Companion Bills

No companion bills found.

Previously Filed As

TX SB309

Relating to COVID-19 prevention and treatment information provided to individuals receiving a COVID-19 viral test.

TX HB989

Relating to the establishment of a higher education plan for human papillomavirus education and prevention.

TX SB2241

Relating to the establishment of a higher education plan for human papillomavirus education and prevention.

TX HB1424

Relating to individual treatment plans for inmates.

TX SB14

Relating to prohibitions on the provision to certain children of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and on the use of public money or public assistance to provide those procedures and treatments.

TX HB1686

Relating to prohibitions on the provision to certain children of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and on the use of public money or public assistance to provide those procedures and treatments.

TX SB625

Relating to prohibitions on the provision to certain children of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and on the use of public money or public assistance to provide those procedures and treatments.

TX SB989

Relating to health benefit plan coverage for certain biomarker testing.

TX SB1029

Relating to civil liability for, governmental health plan coverage of, and public funding for gender modification procedures and treatments.

TX HB3188

Relating to health benefit plan coverage for certain biomarker testing.

Similar Bills

No similar bills found.